Product Information
BENICAR HCT 20-12.5 MG TABLET is a brand product labeled by Cosette Pharmaceuticals, Inc., priced at $11.3168 per EA under NDC 00713086330. Its NADAC has been published 167 times since Apr 19, 2023.
Strength
12.5; 20 mg/1; mg/1
Manufacturer
Cosette Pharmaceuticals, Inc.NDC
00713086330
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMILApproval Type
New Drug (NDA)
FDA Application
NDA021532On Market Since
9/1/2022
Pharmacological Classes
Price Statistics
The NADAC for BENICAR HCT 20-12.5 MG TABLET has been published 167 times since Apr 19, 2023, and over the history we have for it it has risen 32.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.3168 per EA |
|---|---|
| All-time high | $11.3168 (Jun 24, 2026) |
| All-time low | $8.5158 (Apr 19, 2023) |
| 52-week high | $11.3168 |
| 52-week low | $10.2739 |
| Median price | $10.2739 |
| Average price | $10.0031 |
| Largest weekly change | +10.0% (Sep 25, 2024) |
| Weeks tracked | 167 |
| Tracking since | Apr 19, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the olmesartan medoxomil-hydrochlorothiazide market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of BENICAR HCT 20-12.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BENICAR HCT 20-12.5 MG TABLET, manufactured by Cosette Pharmaceuticals, Inc., is $11.3168 per EA (NDC 00713086330), effective Jun 24, 2026.
How has the price of BENICAR HCT 20-12.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BENICAR HCT 20-12.5 MG TABLET has risen 32.9%. It has been tracked across 167 weekly CMS publications since Apr 19, 2023.
What are the highest and lowest recorded NADAC prices for BENICAR HCT 20-12.5 MG TABLET?
Since Apr 19, 2023, the NADAC for BENICAR HCT 20-12.5 MG TABLET has ranged from a low of $8.5158 (Apr 19, 2023) to a high of $11.3168 (Jun 24, 2026), with a median of $10.2739 per EA.
Are there cheaper alternatives to BENICAR HCT 20-12.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of BENICAR HCT 20-12.5 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures BENICAR HCT 20-12.5 MG TABLET?
BENICAR HCT 20-12.5 MG TABLET (NDC 00713086330) is labeled by Cosette Pharmaceuticals, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification